Clascoterone Cream 1%
Phase 2Recruiting 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Papular-pustular Rosacea
Conditions
Papular-pustular Rosacea, Papulopustular Rosacea (PPR), Papulopustular Rosacea
Trial Timeline
Mar 14, 2025 → Sep 30, 2025
NCT ID
NCT06952517About Clascoterone Cream 1%
Clascoterone Cream 1% is a phase 2 stage product being developed by Sun Pharmaceutical for Papular-pustular Rosacea. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06952517. Target conditions include Papular-pustular Rosacea, Papulopustular Rosacea (PPR), Papulopustular Rosacea.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06952517 | Phase 2 | Recruiting |
Other Products from Sun Pharmaceutical
Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
AmifostineApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85